Resources
QA Director Nancy Boxx Weighs In On FDA Draft Guidance On Use of Natural History Studies
In March, The FDA released a draft guidance on the use of natural history studies in rare disease clinical trials. […]
April 22, 2019
QA Director Nancy Boxx Comments on New FDA Guidances in Cancer Trials
Nancy Boxx, ARG Director of Quality Assurance, has provided comments for a piece on Outsourcing-Pharma.com that addresses the new FDA […]
March 15, 2019
ACRP Interviews Technology "Evangelist" (and CTO) Hunter Walker
Hunter Walker was recently interviewed by Michael Causey of the Association of Clinical Research Professionals (ACRP) about using technology to […]
September 24, 2018
ARG Improves Clinical Trial Performance with Vault CTMS
Greater visibility, proactive trial management, and better study analytics and reporting are top drivers for clinical operations professionals to improve […]
September 12, 2018
ARG in Top 15: 2018 Inc. 5000 By the Numbers
Atlantic Research Group, with 3-year growth of 118%, recently appeared on The 2018 Inc. 5000 list of the fastest-growing private companies […]
August 23, 2018
LPLV 2 Months Ahead of Schedule
ARG CEO Paul Bishop just received the following feedback from a Global Pharmaceutical Sponsor: ARG is a rare disease-focused contract […]
July 17, 2018